AUA Newsworthy Webinar: Update on PSMA PET/CT in Prostate Cancer & the Unmet Need for Imaging of RCC
Автор: AmerUrological
Загружено: 2025-10-21
Просмотров: 931
In this webinar, attendees will learn how advanced imaging with 68Gallium PSMA 11 enhances clinical decision-making in prostate cancer. Attendees will also examine diagnostic PET/CT in renal cancer utilizing 89Zr-girentuximab as evidenced by the ZIRCON study.
This is a non-CME, company-led program developed and sponsored by Telix Pharmaceuticals, intended for healthcare professionals only. The content of this company-directed program is not sponsored or endorsed by the American Urological Association (AUA).
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: